Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism

• Hongfei Ge,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Helene Baribault,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Steven Vonderfecht,

  Affiliation Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Bryan Lemon,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Jennifer Weiszmann,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Jonitha Gardner,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Ki Jeong Lee,

  Affiliation Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Jamila Gupte,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Paramita Mookherjee,

  Affiliation Amgen Inc., Seattle, Washington, United States of America

  ⨯
• Minghan Wang,

  Affiliation Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Jackie Sheng,

  Affiliation Amgen Inc., Thousand Oaks, California, United States of America

  ⨯
• Xinle Wu,

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯
• Yang Li

  * E-mail: yangl@amgen.com

  Affiliation Amgen Inc., San Francisco, California, United States of America

  ⨯